COVID-HEART

The main aims of this study are, for a UK population, to characterise the prevalence and extent of myocardial involvement from COVID-19 infection, to assess recovery status at 6 months, and to understand the impact on patient quality of life and functional capacity. As part of the COVID-HEART protocol, there is a blood biomarker and genetic sub-study which participants will have the option of participating in alongside the main study.

Contact Information

Email:
su47@leicester.ac.uk
Telephone:
0116 204 4786
Address:

University of Leicester
Cardiovascular Sciences
Glenfield General Hospital
Groby Road
Leicester
Leicestershire
LE3 9QP
England

Last Updated: 17/02/2021


Annual Statistics

Year Access Requests Received Access Requests Approved
Internal External Commercial Internal External Commercial
2015 N/A N/A N/A N/A N/A N/A
2016 N/A N/A N/A N/A N/A N/A
2017 N/A N/A N/A N/A N/A N/A
2018 N/A N/A N/A N/A N/A N/A
2019 N/A N/A N/A N/A N/A N/A
2020 N/A N/A N/A N/A N/A N/A
2021 N/A N/A N/A N/A N/A N/A